10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001628280-23-027771`
Period End Date	20230630
Filing Date	20230807
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	arwr-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 88 Cash Flow Statement 62 Stockholders Equity 51

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	290.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	107.10M	shares	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$105.33M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	105.96M	shares	Point-in-time
Cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$108.00M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	105.96M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	107.10M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$1.25M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$1.41M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$268.39M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$346.37M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$7.29M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$10.05M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.16M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$20.20M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$405.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$470.17M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$231.37M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$110.30M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$10.69M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$11.96M	USD	Point-in-time
Long-term investments	`HeldToMaturitySecuritiesNoncurrent`	$105.87M	USD	Point-in-time
Long-term investments	`HeldToMaturitySecuritiesNoncurrent`	$42.76M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$40.67M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$58.29M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$210.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$218.00K	USD	Point-in-time
Total Assets	`Assets`	$795.86M	USD	Point-in-time
Total Assets	`Assets`	$691.94M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.87M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$46.86M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$38.19M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$12.25M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$4.43M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.82M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.78M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$16.91M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$74.10M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$138.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$70.23M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$79.91M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$78.80M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$55.95M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	-	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	$263.06M	USD	Point-in-time
Liability related to the sale of future royalties	`RoyaltiesLiabilityNoncurrent`	-	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$669.00K	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$343.64M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$134.75M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 and 145,000 shares; issued and outstanding 107,102 and 105,960 shares	`CommonStockValue`	$199.00K	USD	Point-in-time
Common stock, $0.001 par value: Authorized 290,000 and 145,000 shares; issued and outstanding 107,102 and 105,960 shares	`CommonStockValue`	$198.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.28B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.22B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-136.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-411.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-916.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-820.75M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders equity	`StockholdersEquity`	$364.83M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders equity	`StockholdersEquity`	$398.52M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$17.16M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$19.82M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$381.99M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$396.37M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$452.27M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$465.11M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$474.18M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$372.56M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
Total noncontrolling interest and stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$691.94M	USD	Point-in-time
Total Liabilities, Noncontrolling Interest and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$795.86M	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$15.82M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$224.64M	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$211.66M	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$32.41M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$213.93M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$253.33M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$72.18M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$94.76M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$67.98M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$23.77M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$92.40M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$33.14M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$118.53M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$321.31M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$105.32M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$306.33M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-72.91M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-96.67M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-94.68M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-102.70M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$11.41M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterestAndDividend`	$4.17M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$1.24M	USD	1 Quarter
Interest income	`InvestmentIncomeInterestAndDividend`	$3.45M	USD	3 Qtrs
Interest expense	`InterestExpense`	-	USD	3 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$5.16M	USD	1 Quarter
Interest expense	`InterestExpense`	$13.06M	USD	3 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$821.00K	USD	3 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$-377.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$675.00K	USD	3 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$306.00K	USD	1 Quarter
Total other (loss) income	`NonoperatingIncomeExpense`	$-680.00K	USD	1 Quarter
Total other (loss) income	`NonoperatingIncomeExpense`	$4.12M	USD	3 Qtrs
Total other (loss) income	`NonoperatingIncomeExpense`	$-829.00K	USD	3 Qtrs
Total other (loss) income	`NonoperatingIncomeExpense`	$863.00K	USD	1 Quarter
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-90.55M	USD	3 Qtrs
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-97.50M	USD	3 Qtrs
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-72.05M	USD	1 Quarter
Loss before income tax expense and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-103.38M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$759.00K	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$742.00K	USD	1 Quarter
Net loss including noncontrolling interest	`ProfitLoss`	$-98.26M	USD	3 Qtrs
Net loss including noncontrolling interest	`ProfitLoss`	$-104.12M	USD	1 Quarter
Net loss including noncontrolling interest	`ProfitLoss`	$-72.05M	USD	1 Quarter
Net loss including noncontrolling interest	`ProfitLoss`	$-90.55M	USD	3 Qtrs
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.66M	USD	3 Qtrs
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to noncontrolling interest, net of tax	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.18M	USD	1 Quarter
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-90.55M	USD	3 Qtrs
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-41.33M	USD	1 Quarter
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-95.60M	USD	3 Qtrs
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$44.37M	USD	1 Quarter
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-62.87M	USD	1 Quarter
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$48.67M	USD	1 Quarter
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-102.95M	USD	1 Quarter
Net loss attributable to Arrowhead Pharmaceuticals, Inc.	`NetIncomeLoss`	$-72.05M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.90	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.86	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.68	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.96	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.96	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.86	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.90	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.68	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	106.60M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	107.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	105.75M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	105.27M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.27M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	107.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.75M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	106.60M	shares	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-39.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-79.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-74.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-71.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-275.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-122.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-104.20M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-72.08M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-90.62M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-98.53M	USD	3 Qtrs

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-98.26M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-104.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-72.05M	USD	1 Quarter
Net loss	`ProfitLoss`	$-90.55M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$91.70M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$59.95M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$8.63M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$7.76M	USD	3 Qtrs
(Accretion) amortization of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-2.01M	USD	3 Qtrs
(Accretion) amortization of note premiums/discounts	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$1.03M	USD	3 Qtrs
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	-	USD	3 Qtrs
Non-cash interest expense on liability related to the sale of future royalties	`NonCashInterestExpenseLiabilityRelatedToSaleOfFutureRoyalties`	$13.06M	USD	3 Qtrs
Unrealized losses on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-5.75M	USD	3 Qtrs
Unrealized losses on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-164.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-10.02M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.87M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-27.91M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.00M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.56M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-32.08M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.71M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-87.10M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-113.14M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$3.73M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$1.16M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-67.39M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-128.63M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$112.83M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.07M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$233.98M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$223.39M	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$220.15M	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$201.59M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-126.66M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-41.86M	USD	3 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$2.23M	USD	3 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$4.33M	USD	3 Qtrs
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	-	USD	3 Qtrs
Proceeds from the sale of future royalties	`ProceedsFromSaleOfFutureRoyalties`	$250.00M	USD	3 Qtrs
Proceeds from investment in joint venture	`ProceedsFromContributedCapital`	-	USD	3 Qtrs
Proceeds from investment in joint venture	`ProceedsFromContributedCapital`	$60.00M	USD	3 Qtrs
Proceeds from additional tenant improvement allowance	`ProceedsFromTenantImprovementAllowance`	$669.00K	USD	3 Qtrs
Proceeds from additional tenant improvement allowance	`ProceedsFromTenantImprovementAllowance`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$252.90M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$64.33M	USD	3 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.40M	USD	3 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-44.92M	USD	3 Qtrs
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-275.00K	USD	3 Qtrs
Effect of exchange rate on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-70.00K	USD	3 Qtrs
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$108.00M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.44M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$184.43M	USD	Point-in-time
BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$105.33M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$108.00M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.44M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$184.43M	USD	Point-in-time
END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$105.33M	USD	Point-in-time
Interest paid	`InterestPaidNet`	-	USD	3 Qtrs
Interest paid	`InterestPaidNet`	-	USD	3 Qtrs
Income taxes (paid) refunded	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Income taxes (paid) refunded	`IncomeTaxesPaidNet`	-	USD	3 Qtrs

Stockholders Equity 51 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$381.99M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$396.37M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$452.27M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$465.11M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$474.18M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$372.56M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.95M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$24.50M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.39M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$33.39M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$33.80M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.61M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$520.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.14M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$599.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$576.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.15M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.54M	USD	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	343,801.00	shares	3 Qtrs
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Common stock - restricted stock units vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-39.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-79.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-74.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-71.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-275.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-122.00K	USD	1 Quarter
Interest in joint venture	`MinorityInterestDecreaseFromRedemptions`	$999.00K	USD	1 Quarter
Interest in joint venture	`MinorityInterestDecreaseFromRedemptions`	$486.00K	USD	1 Quarter
Interest in joint venture	`MinorityInterestDecreaseFromRedemptions`	$1.18M	USD	1 Quarter
Interest in joint venture	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$60.00M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-90.55M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-41.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-95.60M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$44.37M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-62.87M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$48.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-102.95M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-72.05M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$381.99M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$396.37M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$452.27M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$465.11M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$474.18M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$372.56M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.82M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$418.34M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.